GC Pharma’s ‘Perami Flu’ increases quadruple
Along with the global record-breaking cold wave and flu(influenza), an injection-type flu treatment has attracted people as a new treatment option.
GC Pharma(CEO Eun-Cheol Huh) announced on the 1st that ‘Perami Flu,’ an injection-type flu treatment, made about KRW 2.4 billion sales this January...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
